The Virginia Department of Criminal Justice Services (DCJS) is accepting applications for the CY 2027-2029 Virginia Opioid Use Reduction and Jail-Based Substance Use Disorder Treatment and Transition Fund (JSUT) Grant Program, OGMS funding opportunity 579019. The program supports substance use disorder treatment and transition services for people incarcerated in Virginia local and regional jails.
Funding and Deadline
DCJS anticipates approximately $900,000 in total special-fund awards. Individual subgrant requests may not exceed $150,000 for the full 36-month award period from January 1, 2027 through December 31, 2029. No match is required. Awards are cost-reimbursement based, and indirect costs are not permitted.
Applications are due in OGMS on October 13, 2026 at 12:00 noon. The controlling guidelines do not separately state a time zone, so Atlas does not infer one. Under Atlas’s 48-hour new-applicant outreach rule, new outreach must stop by October 11, 2026 at 12:00 noon on the same published clock basis unless DCJS authoritatively changes the deadline.
Eligible Applicants
This funding opportunity is limited to Virginia local and regional jails. Applicants must not be excluded or debarred from doing business with the Commonwealth, must hold current professional and state licenses and certifications as required for the proposed project, and must be planning, implementing, expanding, or enhancing SUD treatment or transition services for people with SUD in a local or regional jail. Current DCJS grantees may also face compliance consequences if required reports or claims are more than 30 days overdue at the application deadline without an approved extension.
Program Scope
Allowable program models may include medication-assisted treatment or medications for opioid use disorder, addiction recovery and other SUD services, counseling and behavioral-health treatment, reentry planning, transitional support, overdose-prevention education, naloxone access, referrals to community treatment and recovery-support providers, and connections to health insurance, medication, housing, transportation, peer support and other recovery services.
Consultants, Equipment and N9+ Fit
The guidelines allow third-party consultant services when reasonable, necessary and tied to grant goals. Equipment may be funded on a case-by-case basis when needed to meet project goals, and applicants must document cost reasonableness and explain why the item is essential. The program does not fund capital construction, renovation, remodeling, land acquisition, or vehicle purchases.
Atlas Opportunity Score: 94/100. N9+ Fit Score: 62/100 — CONDITIONAL. N9+ is not the applicant and should not be positioned as the program itself. A defensible role could exist only when an eligible jail documents a project-specific clinical need, such as clinician-guided remote assessment or treatment support that is necessary to an approved jail-based SUD program. Equipment is allowable only case by case and must be essential and reasonably priced, so the maximum defensible N9+ revenue is applicant-specific and cannot be treated as the full grant amount. Dr. Miltie is best positioned, if at all, as a technology/vendor or implementation partner to an eligible jail. QC Healthcare may have a stronger service-partner path where appropriately licensed clinical services, counseling, screening, treatment or care-transition support are required.
Application Operations
Applications must be submitted through DCJS’s Online Grants Management System (OGMS). The optional applicant webinar is scheduled for October 2, 2026 at 10:00 a.m. DCJS identifies Cynthia Nwarache as the grant coordinator. Applicants should use the current CY 2027-2029 guidelines, OGMS requirements, and any later DCJS amendments or clarifications as controlling sources.